<p>Maclusa 400/100mg Tablets are a prescription antiviral medicine available in Pakistan. It contains Sofosbuvir 400mg and Velpatasvir 100mg, commonly used in hepatitis C treatment under specialist medical supervision. Check price, size, manufacturer details, precautions, and complete product information.</p>
Maclusa 400/100mg Tablets are a prescription antiviral medication used in the management of chronic hepatitis C virus (HCV) infection. The tablet contains two active ingredients:
This combination belongs to a class of medicines known as direct-acting antiviral agents (DAAs). These medicines work by targeting specific steps in the hepatitis C virus life cycle and helping the body clear the infection.
Maclusa should only be taken under the guidance of a qualified healthcare professional, especially a liver specialist or infectious disease doctor.
Maclusa is a fixed-dose combination tablet containing Sofosbuvir and Velpatasvir. It is designed to provide a complete antiviral treatment approach in a single daily dose.
Hepatitis C is a viral infection that affects the liver. Without proper treatment, chronic hepatitis C may lead to complications such as:
Modern antiviral treatments such as Sofosbuvir and Velpatasvir have improved hepatitis C management by targeting the virus directly.
Maclusa 400/100mg is mainly used for:
Maclusa is prescribed for adults with chronic hepatitis C infection. It may be effective against different hepatitis C genotypes depending on medical assessment.
Doctors consider factors such as:
Maclusa contains two antiviral components.
Sofosbuvir is an antiviral medicine that blocks an enzyme needed by hepatitis C virus replication.
It helps:
Velpatasvir works by targeting another important protein involved in the hepatitis C virus life cycle.
Together, both ingredients provide a combination approach against HCV.
When prescribed appropriately, Maclusa may help:
Treatment success depends on several factors, including:
The usual treatment plan is determined by a doctor.
Factors affecting dosage and duration include:
Do not change the dose or stop treatment without medical advice.
General instructions:
Missing doses may affect treatment effectiveness.
Like all medicines, Maclusa may cause side effects.
Possible side effects include:
Some patients may experience additional reactions depending on their health condition and other medicines.
Contact a healthcare provider if side effects become severe.
Inform your doctor before starting Maclusa if you have:
Also tell your doctor about all medicines you are currently taking.
Maclusa may interact with certain medicines.
Tell your healthcare provider if you use:
Some medicines may reduce effectiveness or increase risks.
Patients who are pregnant, planning pregnancy, or breastfeeding should discuss Maclusa use with a doctor.
Medical guidance is important to evaluate safety.
Store Maclusa tablets:
Do not use tablets after expiry.
Maclusa may be available through pharmacies and healthcare suppliers in Pakistan.
Prices may vary depending on:
Always buy medicines from reliable sources.
Before using Maclusa, check:
Avoid products with damaged packaging.
Maclusa is used for treatment of chronic hepatitis C infection under medical supervision.
No. It should only be used after evaluation by a qualified doctor.
Treatment duration depends on patient condition and doctor recommendation.
Sofosbuvir and Velpatasvir combinations are widely used in hepatitis C management, but results depend on individual factors.
It may be available through licensed pharmacies depending on stock availability.
No reviews yet. Be the first to review this product!